FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199288600> ?p ?o ?g. }

• W3199288600 endingPage "121142" @default.
• W3199288600 startingPage "121142" @default.
• W3199288600 abstract "There is a lack of actively targeting drug delivery carriers for the topical treatment of epidermal diseases, which results in drug waste and an increased incidence of toxic side effects in the clinic. We recently discovered that epidermal cells (HaCaT cells) have homologous targeting functions and developed HaCaT cell membrane-coated pH-sensitive micelles for therapeutic active targeting of skin disease. We encapsulated shikonin in these biomimetic nanocarriers and found that the nanocarriers accumulated mainly in the active epidermis when delivered with karaya gum-fabricated water-soluble microneedles. The nanocarriers were internalized by the target cells, resulting in swelling of histidine fragments with protonation and subsequent triggering of drug release, which increased the therapeutic efficacy of shikonin against imiquimod-induced psoriatic epidermal hyperplasia. This emerging biomimetic delivery strategy is a new approach for improving the treatment of skin diseases and is also very promising for use in the field of cosmetics. Additionally, we found abnormally high protein expression of Na+/K+-ATPase in diseased skin; thus, this protein may be a biomarker of psoriasis." @default.
• W3199288600 created "2021-09-27" @default.
• W3199288600 creator A5005244980 @default.
• W3199288600 creator A5005322043 @default.
• W3199288600 creator A5015647468 @default.
• W3199288600 creator A5018331661 @default.
• W3199288600 creator A5030447905 @default.
• W3199288600 creator A5030927081 @default.
• W3199288600 creator A5036016529 @default.
• W3199288600 creator A5044298582 @default.
• W3199288600 creator A5076381011 @default.
• W3199288600 creator A5082708885 @default.
• W3199288600 creator A5083896542 @default.
• W3199288600 date "2021-11-01" @default.
• W3199288600 modified "2023-10-14" @default.
• W3199288600 title "Keratinocyte membrane-mediated nanodelivery system with dissolving microneedles for targeted therapy of skin diseases" @default.
• W3199288600 cites W1577071491 @default.
• W3199288600 cites W1820447334 @default.
• W3199288600 cites W1837832684 @default.
• W3199288600 cites W1934712179 @default.
• W3199288600 cites W1939997832 @default.
• W3199288600 cites W1969913009 @default.
• W3199288600 cites W1971708477 @default.
• W3199288600 cites W1971849282 @default.
• W3199288600 cites W1979335059 @default.
• W3199288600 cites W1980052502 @default.
• W3199288600 cites W1981636071 @default.
• W3199288600 cites W1982926364 @default.
• W3199288600 cites W1987751343 @default.
• W3199288600 cites W1994629000 @default.
• W3199288600 cites W2013315584 @default.
• W3199288600 cites W2070668760 @default.
• W3199288600 cites W2072554913 @default.
• W3199288600 cites W2074432058 @default.
• W3199288600 cites W2078830859 @default.
• W3199288600 cites W2090570874 @default.
• W3199288600 cites W2200472334 @default.
• W3199288600 cites W2272408267 @default.
• W3199288600 cites W2344070907 @default.
• W3199288600 cites W2475165153 @default.
• W3199288600 cites W2516918670 @default.
• W3199288600 cites W2520890213 @default.
• W3199288600 cites W2554324946 @default.
• W3199288600 cites W2595165451 @default.
• W3199288600 cites W2765376601 @default.
• W3199288600 cites W2767149862 @default.
• W3199288600 cites W2792737160 @default.
• W3199288600 cites W2793854337 @default.
• W3199288600 cites W2793967425 @default.
• W3199288600 cites W2804076430 @default.
• W3199288600 cites W2903585874 @default.
• W3199288600 cites W2907493741 @default.
• W3199288600 cites W2923485026 @default.
• W3199288600 cites W2924754025 @default.
• W3199288600 cites W2932020126 @default.
• W3199288600 cites W2942754315 @default.
• W3199288600 cites W2949064350 @default.
• W3199288600 cites W2956371126 @default.
• W3199288600 cites W2962103572 @default.
• W3199288600 cites W2965693490 @default.
• W3199288600 cites W2981322643 @default.
• W3199288600 cites W2985731736 @default.
• W3199288600 cites W2987413771 @default.
• W3199288600 cites W2988972782 @default.
• W3199288600 cites W2996998369 @default.
• W3199288600 cites W3004514673 @default.
• W3199288600 cites W3005709647 @default.
• W3199288600 cites W3013635432 @default.
• W3199288600 cites W3016544053 @default.
• W3199288600 cites W3022531941 @default.
• W3199288600 cites W3083693060 @default.
• W3199288600 cites W3127469402 @default.
• W3199288600 cites W3130851263 @default.
• W3199288600 cites W3150393082 @default.
• W3199288600 cites W3154545544 @default.
• W3199288600 doi "https://doi.org/10.1016/j.biomaterials.2021.121142" @default.
• W3199288600 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34571433" @default.
• W3199288600 hasPublicationYear "2021" @default.
• W3199288600 type Work @default.
• W3199288600 sameAs 3199288600 @default.
• W3199288600 citedByCount "32" @default.
• W3199288600 countsByYear W31992886002022 @default.
• W3199288600 countsByYear W31992886002023 @default.
• W3199288600 crossrefType "journal-article" @default.
• W3199288600 hasAuthorship W3199288600A5005244980 @default.
• W3199288600 hasAuthorship W3199288600A5005322043 @default.
• W3199288600 hasAuthorship W3199288600A5015647468 @default.
• W3199288600 hasAuthorship W3199288600A5018331661 @default.
• W3199288600 hasAuthorship W3199288600A5030447905 @default.
• W3199288600 hasAuthorship W3199288600A5030927081 @default.
• W3199288600 hasAuthorship W3199288600A5036016529 @default.
• W3199288600 hasAuthorship W3199288600A5044298582 @default.
• W3199288600 hasAuthorship W3199288600A5076381011 @default.
• W3199288600 hasAuthorship W3199288600A5082708885 @default.
• W3199288600 hasAuthorship W3199288600A5083896542 @default.
• W3199288600 hasConcept C105702510 @default.
• W3199288600 hasConcept C118995209 @default.
• W3199288600 hasConcept C16005928 @default.

• next